Relx Plc (NYSE:RELX) Holdings Raised by Boston Common Asset Management LLC

Boston Common Asset Management LLC lifted its stake in Relx Plc (NYSE:RELX - Free Report) by 12.8% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 106,248 shares of the technology company's stock after acquiring an additional 12,086 shares during the period. Boston Common Asset Management LLC's holdings in Relx were worth $5,356,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently modified their holdings of RELX. CENTRAL TRUST Co raised its stake in shares of Relx by 1,290.2% in the 4th quarter. CENTRAL TRUST Co now owns 570 shares of the technology company's stock worth $26,000 after buying an additional 529 shares in the last quarter. Transce3nd LLC bought a new stake in shares of Relx in the 4th quarter worth $40,000. Sierra Ocean LLC bought a new stake in shares of Relx in the 4th quarter worth $43,000. Brown Brothers Harriman & Co. lifted its stake in Relx by 218.5% during the fourth quarter. Brown Brothers Harriman & Co. now owns 965 shares of the technology company's stock valued at $44,000 after purchasing an additional 662 shares during the last quarter. Finally, Private Trust Co. NA lifted its stake in Relx by 19.2% during the fourth quarter. Private Trust Co. NA now owns 1,237 shares of the technology company's stock valued at $56,000 after purchasing an additional 199 shares during the last quarter. Institutional investors own 15.02% of the company's stock.

Relx Stock Up 0.4%

Shares of RELX stock traded up $0.24 on Monday, reaching $54.16. 369,100 shares of the company's stock traded hands, compared to its average volume of 712,986. Relx Plc has a 12-month low of $43.45 and a 12-month high of $56.33. The company has a debt-to-equity ratio of 1.46, a quick ratio of 0.47 and a current ratio of 0.52. The company has a market capitalization of $99.98 billion, a P/E ratio of 29.12, a price-to-earnings-growth ratio of 2.73 and a beta of 0.86. The business's 50 day moving average price is $52.28 and its two-hundred day moving average price is $49.47.

Analyst Upgrades and Downgrades

Several research firms recently commented on RELX. The Goldman Sachs Group began coverage on shares of Relx in a research note on Wednesday, March 26th. They set a "buy" rating for the company. Wall Street Zen lowered shares of Relx from a "buy" rating to a "hold" rating in a research note on Tuesday, March 4th. Barclays raised shares of Relx from an "equal weight" rating to an "overweight" rating in a research note on Friday, March 14th. Finally, Morgan Stanley reaffirmed an "overweight" rating on shares of Relx in a research note on Wednesday, April 16th. One equities research analyst has rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, Relx has an average rating of "Buy".

About Relx

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.